| De innovatione: The concept of innovation for medical technologies and its implications for healthcare policy-making O Ciani, P Armeni, PR Boscolo, M Cavazza, C Jommi, R Tarricone Health Policy and Technology 5 (1), 47-64, 2016 | 85 | 2016 |
| Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe M Cavazza, Y Kodra, P Armeni, M De Santis, J López-Bastida, ... The European Journal of Health Economics 17, 19-29, 2016 | 80 | 2016 |
| The social burden and quality of life of patients with haemophilia in Italy Y Kodra, M Cavazza, A Schieppati, M De Santis, P Armeni, R Arcieri, ... Blood Transfusion 12 (Suppl 3), s567, 2014 | 74 | 2014 |
| Social/economic costs and quality of life in patients with haemophilia in Europe M Cavazza, Y Kodra, P Armeni, M De Santis, J López-Bastida, ... The European Journal of Health Economics 17, 53-65, 2016 | 73 | 2016 |
| Health care costs of influenza-related episodes in high income countries: a systematic review C Federici, M Cavazza, F Costa, C Jommi PLoS One 13 (9), e0202787, 2018 | 53 | 2018 |
| Stakeholders involvement by HTA Organisations: Why is so different? M Cavazza, C Jommi Health policy 105 (2-3), 236-245, 2012 | 45 | 2012 |
| Mapping health services access: National and cross border issues (HealthAccess) Final report. R Busse, M Worz, T Foubister, E Mossialos, PC Berman European Health Management Association (EHMA), 2006 | 31 | 2006 |
| Governing through evidence: a study of technological innovation in health care V Mele, A Compagni, M Cavazza Journal of Public Administration Research and Theory 24 (4), 843-877, 2014 | 26 | 2014 |
| Factors influencing adherence to adjuvant endocrine therapy in breast cancer-treated women: using real-world data to inform a switch from acute to chronic disease management M Cavazza, H Banks, M Ercolanoni, G Cukaj, G Bianchi, G Capri, F Longo Breast cancer research and treatment 183, 189-199, 2020 | 23 | 2020 |
| Social economic costs, health-related quality of life and disability in patients with Cri Du Chat Syndrome Y Kodra, M Cavazza, M de Santis, A Guala, ME Liverani, P Armeni, ... International Journal of Environmental Research and Public Health 17 (16), 5951, 2020 | 13 | 2020 |
| Reflections on the importance of cost of illness analysis in rare diseases: a proposal P Armeni, M Cavazza, E Xoxi, D Taruscio, Y Kodra International Journal of Environmental Research and Public Health 18 (3), 1101, 2021 | 11 | 2021 |
| Sviluppo e prospettive dei fondi integrativi del Servizio Sanitario Nazionale M Cavazza, C De Pietro Rapporto OASI 2011 L'aziendalizzazione della sanità in Italia, 161-188, 2011 | 11 | 2011 |
| BURQOL-RD Research Network M Cavazza Kodra, Y, 19-29, 2016 | 10 | 2016 |
| Organizzazione e gestione delle sperimentazioni cliniche F Costa, C Jommi, M Cavazza EGEA spa, 2017 | 9 | 2017 |
| The economic impact of compassionate use of medicines C. Jommi, F. Pantellini, L. Stagi, M. Verykiou, M. Cavazza BMC Health Services Research 21 (1303), 1 - 13, 2021 | 8 | 2021 |
| Il processo decisionale negli Istituti di Health Technology Assessment C Jommi, M Cavazza Rapporto OASI 2009 L'aziendalizzazione della sanità in Italia, 157-187, 2009 | 7 | 2009 |
| Patient access to oral nutritional supplements: Which policies count? M Cavazza, H Banks, M Muscaritoli, M Rondanelli, E Zandonà, C Jommi Nutrition 69, 110560, 2020 | 6 | 2020 |
| L'innovazione nell'assicurazione salute M Cavazza, M Del Vecchio, C De Pietro, V Rappini EGEA spa, 2017 | 5 | 2017 |
| Assetto istituzionale e scelte di gestione in sei fondi sanitari M Cavazza, C DE PIETRO Rapporto OASI L'aziendalizzazione della sanità in Italia, 185-215, 2012 | 5 | 2012 |
| La ricerca clinica in Italia: quanto, come viene finanziata e suoi effetti sul sistema M Cavazza, A Bertolani, C Jommi Il valore della ricerca clinica indipendente in Italia. Libro Bianco sulla …, 2020 | 4 | 2020 |
